Human dendritic cell subsets in NOD/SCID mice engrafted with CD34+ hematopoietic progenitors

被引:48
|
作者
Palucka, AK
Gatlin, J
Blanck, JP
Melkus, MW
Clayton, S
Ueno, H
Kraus, ET
Cravens, P
Bennett, L
Padgett-Thomas, A
Marches, F
Islas-Ohlmayer, M
Garcia, JV
Banchereau, J
机构
[1] Baylor Inst Immunol Res, Dallas, TX 75204 USA
[2] Univ Texas, SW Med Ctr, Dallas, TX 75230 USA
关键词
D O I
10.1182/blood-2003-02-0384
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Distinct human dendritic cell (DC) subsets differentially control immunity. Thus, insights into their in vivo functions are important to understand the launching and modulation of immune responses. We show that nonobese diabetic/LtSz-scid/scid (NOD/SCID) mice engrafted with human CD34(+) hematopoietic progenitors develop human myeloid and plasmacytoid DCs. The skin displays immature DCs expressing Langerin, while other tissues display interstitial DCs. Myeloid DCs from these mice induce proliferation of allogeneic CD4 T cells in vitro, and bone marrow human cells containing plasmacytoid DCs release interferon-alpha (IFN-alpha) upon influenza virus exposure. Injection of influenza virus into reconstituted mice triggers IFN-alpha release and maturation of mDCs. Thus, these mice may provide a model to study the pathophysiology of human DC subsets. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:3302 / 3310
页数:9
相关论文
共 50 条
  • [41] Recovery of lymphocyte and dendritic cell subsets after autologous CD34+ cell transplantation
    Galy, A
    Rudraraju, S
    Baynes, R
    Klein, J
    BONE MARROW TRANSPLANTATION, 2000, 25 (12) : 1249 - 1255
  • [42] Fibronectin-facilitated gene transfer of human interferon alpha into human CD34+ hematopoietic progenitors:: Long-term expression in vitro and in SCID mice.
    Quan, S
    Feldman, E
    Yang, L
    Farley, T
    Tani, K
    Asano, S
    Ahmed, T
    Abraham, NG
    BLOOD, 1998, 92 (10) : 380B - 380B
  • [43] EVALUATION OF ALLOIMMUNE RESPONSES IN HUMANIZED NOD/SCID/IL2RGNULL MICE FOLLOWING HUMAN CD34+ STEM CELL TRANSPLANTATION
    Hartwig, U. F.
    Hemmerling, J.
    Hoffmann, J.
    Andre, M. C.
    Handgretinger, R.
    Huber, C.
    Herr, W.
    Meyer, R. G.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 130 - 130
  • [44] Human CD34+ cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with equivalent efficiency as CD34+ cells mobilized by G-CSF.
    Hess, DA
    Bonde, J
    Craft, TP
    Wirthlin, L
    DiPersio, JF
    Devine, SM
    Nolta, JA
    BLOOD, 2004, 104 (11) : 336A - 336A
  • [45] Human CD8+ memory and EBV-specific T cells show low alloreactivity in vitro and in CD34+ stem cell-engrafted NOD/SCID/IL-2Rγcnull mice
    Thomas, Simone
    Klobuch, Sebastian
    Sommer, Maria
    van Ewijk, Reyn
    Theobald, Matthias
    Meyer, Ralf G.
    Herr, Wolfgang
    EXPERIMENTAL HEMATOLOGY, 2014, 42 (01) : 28 - 38
  • [46] Heart infarct in NOD-SCID mice:: Therapeutic vasculogenesis by transplantation of human CD34+ cells and low dose CD34+KDR+ cells
    Botta, R
    Gao, E
    Stassi, G
    Bonci, D
    Pelosi, E
    Zwas, D
    Patti, M
    Colonna, L
    Baiocchi, M
    Coppola, S
    Ma, X
    Condorelli, G
    Peschle, C
    FASEB JOURNAL, 2004, 18 (10): : 1392 - +
  • [47] Subsets of CD34+ hematopoietic progenitors and platelet recovery after high dose chemotherapy and peripheral blood stem cell transplantation
    Knudsen, LM
    Jensen, L
    Jarlbæk, L
    Hansen, PG
    Hansen, SW
    Drivsholm, L
    Nikolaisen, K
    Gaarsdal, E
    Johnsen, HE
    HAEMATOLOGICA, 1999, 84 (06) : 517 - 524
  • [48] Mobilization of CD34+ hematopoietic progenitor cells in SCID beige mice utilizing flow cytometer
    Zong, Q.
    Vitsky, A.
    Yafawi, R.
    Ko, M.
    Sace, F.
    Malamant, M.
    John-Baptiste, A.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A189 - A189
  • [49] Delayed engraftment of NOD/SCID mice transplanted with ex vivo expanded human CD34+ cord blood cells.
    Güenechea, G
    Segovia, JC
    Albella, B
    Lamana, M
    Ramírez, M
    Regidor, C
    Fernández, MN
    Bueren, JA
    BONE MARROW TRANSPLANTATION, 1999, 23 : S199 - S199
  • [50] About multiple sclerosis, natalizumab, and CD34+ hematopoietic progenitors
    Vuillat, Carine
    Androdias, Geraldine
    Davoust, Nathalie
    Nataf, Serge
    BLOOD, 2008, 112 (01) : 208 - 209